KPTI Estatísticas principais
Alta
7.16
Abrir
7.14
Volume
148.62K
Baixa
6.88
Fechamento anterior
7.18
Valor negociado
1.04M
52 sem. máx.
10.99
Vol. relativo
0.228
Amplitude (%)
3.83%
52 sem. mín.
3.65
Taxa de giro
0.66%
Cap. de Mercado
162.71M
P/L (TTM)
--
P/L (Anual)
--
P/VP
-0.61
P/S
1.08
Lucro por ação (EPS)
-15.087
Dividendo (TTM)
0
Rendimento de dividendos
0.00%
Ações em circulação
22.66M
Unidade monetária
USD
KPTI Desempenho de Preço
7 dia
30 dia
90 dia
180 dia
No acumulado do ano
1 Ano
KPTI Distribuição do fluxo de dinheiro
KPTI Volume diário de venda a descoberto
KPTI Histórico de short interest
KPTI Visão geral da ação
As of 2026-07-23, the Karyopharm Therapeutics Inc. (KPTI) stock price today is 6.98. Based on this price, the company has a market capitalization of $162.71M, with a P/E ratio of --.
On 2026-07-23, KPTI traded between 6.88 and 7.16. Today’s stock price is 1.45% above the daily low and 2.51% below the daily high, placing KPTI na faixa inferior de its most recent trading range.
Trading volume currently stands at 148.62K, compared with an average daily volume of 652.80K. This suggests that trading activity is significativamente abaixo do nível habitual than usual.
Over the past year, Karyopharm Therapeutics Inc. shares have traded between 3.65 and 10.99. At today’s price, KPTI is 91.23% above its 52-week low and 36.49% below its 52-week high.
KPTI Notícias relacionadas
Sobre KPTI
Nome empresa
Karyopharm Therapeutics Inc.
Setor
Health Technology
Indústria
Pharmaceuticals: Major
Trocas
Nasdaq
Número de funcionários
228
Tamanho do lote
100
Site oficial
Unidade monetária
USD
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Related Stocks
KPTI FAQ
© 2026 CoinGlass, all rights reserved
